Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
-486K
-
Total reported value, excl. options
-
$111M
-
Value change
-
-$1.86M
-
Number of buys
-
33
-
Number of sells
-
-33
-
Price
-
$4.29
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q4 2020
85 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q4 2020.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 44.7M outstanding shares and own 57.9% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.95M shares), DIMENSIONAL FUND ADVISORS LP (2.03M shares), VANGUARD GROUP INC (1.83M shares), ROYCE & ASSOCIATES LP (1.67M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (1.61M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1.52M shares), Portolan Capital Management, LLC (1.34M shares), RENAISSANCE TECHNOLOGIES LLC (1.22M shares), ACADIAN ASSET MANAGEMENT LLC (1.1M shares), and Harvey Partners, LLC (993K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.